CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 84 filers reported holding CRISPR THERAPEUTICS AG in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $231,000 | -32.3% | 3,050 | 0.0% | 0.15% | -16.4% |
| Q3 2021 | $341,000 | -31.0% | 3,050 | 0.0% | 0.18% | -38.0% |
| Q2 2021 | $494,000 | +32.8% | 3,050 | 0.0% | 0.30% | +8.5% |
| Q1 2021 | $372,000 | -20.3% | 3,050 | 0.0% | 0.27% | -41.5% |
| Q4 2020 | $467,000 | +46.9% | 3,050 | -19.7% | 0.46% | +31.0% |
| Q3 2020 | $318,000 | +14.0% | 3,800 | 0.0% | 0.36% | -30.9% |
| Q2 2020 | $279,000 | +20.8% | 3,800 | 0.0% | 0.51% | -26.4% |
| Q4 2019 | $231,000 | -45.4% | 3,800 | -47.2% | 0.70% | +120.9% |
| Q2 2018 | $423,000 | +14.3% | 7,200 | -11.1% | 0.32% | +12.1% |
| Q1 2018 | $370,000 | +94.7% | 8,100 | 0.0% | 0.28% | +107.4% |
| Q4 2017 | $190,000 | – | 8,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |